Yi-Hsin Chan
Memorial Hospital of South Bend
Internal medicineSurgeryCardiologyRetrospective cohort studyCohort studyHazard ratioWarfarinVitamin K antagonistDirect thrombin inhibitorHeart failureRivaroxabanDabigatranAtrial fibrillationLower riskConfidence intervalMyocardial infarctionProportional hazards modelDiabetes mellitusMedicineEjection fraction
71Publications
15H-index
751Citations
Publications 77
Newest
#1Tze-Fan Chao (Taipei Veterans General Hospital)H-Index: 48
#2Boyoung Joung (Yonsei University)H-Index: 45
Last. Gregory Y.H. Lip (University of Liverpool)H-Index: 202
view all 11 authors...
Source
#1Tze-Fan Chao (Taipei Veterans General Hospital)H-Index: 7
#2Boyoung Joung (Yonsei University)H-Index: 45
Last. Gregory Y.H. Lip (University of Liverpool)H-Index: 202
view all 11 authors...
The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for cardiologists, neurologists, geriatricians, and general practitioners in the Asia-Pacific region. In these years, many important new data regarding stroke prevention in AF were reported. The practice guidelines subcommittee members comprehensively reviewed updated information on stroke prevention in AF, and summariz...
Source
#1Tze-Fan Chao (Taipei Veterans General Hospital)H-Index: 7
#2Yi-Hsin Chan (Memorial Hospital of South Bend)H-Index: 15
Last. Shih-Ann Chen (Taipei Veterans General Hospital)H-Index: 86
view all 8 authors...
Background null Elderly atrial fibrillation (AF) patients with risk factors of bleeding are often considered ineligible for standard oral anticoagulants (OACs). The ELDERCARE-AF trial recently showed that edoxaban 15mg/day was superior to placebo for preventing stroke or systemic embolism and did not result in a significantly higher incidence of major bleeding. Our aim was to investigate a real-world cohort of AF patients similar to the ELDERCARE-AF cohort, with regard to the impact of direct or...
Source
#1Ying-Chang Tung (Memorial Hospital of South Bend)H-Index: 1
#2Chi-Jen Chang (Memorial Hospital of South Bend)H-Index: 19
Last. Lai-Chu See (CGU: Chang Gung University)H-Index: 65
view all 7 authors...
Clinical outcomes are unknown after ticagrelor treatment in patients with end-stage renal disease (ESRD) who are diagnosed with acute myocardial infarction (AMI). ESRD patients who were on hemodialysis and received dual antiplatelet therapy (DAPT) for AMI between July 2013 and December 2016 were identified in Taiwan's National Health Insurance Research Database. Using stabilized inverse probability of treatment weighting, patients receiving aspirin plus ticagrelor (n = 530) were compared with th...
Source
#1Chih-Hsiang Chang (Memorial Hospital of South Bend)H-Index: 22
#2Shao-Wei Chen (Memorial Hospital of South Bend)H-Index: 15
Last. Yu-Ting Cheng (Memorial Hospital of South Bend)
view all 7 authors...
Acute kidney disease (AKD) is the persistence of renal injury between days 8 and 90 after an initial acute kidney injury (AKI). In this study, we aimed to explore the incidence of AKD, the association between AKD, and patient outcomes after acute type A aortic dissection (type A AAD) surgery. We identified 696 participants who underwent type A AAD surgery. Patients were categorized into stages 1 to 3 or 0 (non-AKD) AKD groups. Outcomes included major adverse kidney events (MAKEs), respiratory fa...
Source
#3Tze-Fan Chao (NYMU: National Yang-Ming University)H-Index: 12
PURPOSE Whether direct oral anticoagulants (DOACs) are more effective and safer than warfarin among Asian patients with non-valvular atrial fibrillation (NVAF) undergoing dialysis remains unclear. METHODS We first compared the risks of ischemic stroke/systemic embolism (IS/SE) and major bleeding associated with DOACs compared with warfarin, in NVAF Asians undergoing dialysis using the Taiwan National Health Insurance Research Database (NHIRD) (Aim 1). Next, we searched PubMed and Medline from Ja...
Source
#1I-Hsien Li (CGU: Chang Gung University)
#2An-Hsun Chou (CGU: Chang Gung University)H-Index: 7
Last. Kuo-Sheng Liu (CGU: Chang Gung University)H-Index: 9
view all 11 authors...
Abstract null null Background null To determine the relationship between hospital surgical volume and mortality risk and valve repair rate in infective endocarditis (IE) surgery. null null null Methods null Using the Taiwan National Health Insurance Research Database (NHIRD), 3873 patients were identified who underwent surgery between 2000 and 2013. The cumulative hospital volume of valve surgery for IE was calculated, and patients were divided into 4 subgroups according to the quartile. Outcome...
Source
#3Tze-Fan Chao (Taipei Veterans General Hospital)H-Index: 12
AIM Sodium-glucose cotransporter 2 inhibitors (SGLT2is) cause an initial decline in estimated glomerular filtration rate (eGFR) in patients with type 2 diabetes mellitus (T2DM). The effect of different eGFR decline following SGLT2i treatment on risks of atrial fibrillation (AF), cardiovascular, and renal events in patients with T2DM are unknown. MATERIALS AND METHODS We used medical data from a multicenter health care provider in Taiwan and recruited 11 769 T2DM patients with baseline/follow-up ...
Source
#1Hsin-Fu Lee (CGU: Chang Gung University)H-Index: 14
#2Yu-Wen Cheng (CGU: Chang Gung University)
Last. Pao-Hsien Chu (Memorial Hospital of South Bend)H-Index: 21
view all 7 authors...
Abstract null null Background null Patients with chronic kidney disease (CKD) and coronary instent restenosis (ISR) treated with drug-coated balloon (DCB) angioplasty have been excluded from randomized controlled trials. We aimed to investigate the clinical impact of CKD stratified by severity, on clinical outcomes for patients with ISR treated with DCB angioplasty. null null null Methods null This cohort study enrolled 1,376 patients treated with DCB angioplasty; 639 CKD patients defined as hav...
Source
#3Tze-Fan Chao (Taipei Veterans General Hospital)H-Index: 12
BACKGROUND There is a controversy over the association between obesity and the risk of renal events in patients with type 2 diabetes mellitus (T2DM). Furthermore, whether body weight (BW) loss following sodium glucose cotransporter 2 inhibitor (SGLT2i) treatment associated with risk of adverse renal events is unknown. METHODS We used medical data from a multi-center healthcare provider in Taiwan, enrolling 8992 T2DM patients with a baseline/following-up BW data available after around 12 weeks of...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.